EVOFEM BIOSCIENCES, INC. Financial and Nonfinancial Liabilities, Fair Value Disclosure
EVOFEM BIOSCIENCES, INC. (EVFM) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $68.72 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2021-11-15
- 2021-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $68.72M.
- 2021-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $44.31M.
- 2021-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $50.89M.
- 2020-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $50.75M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2021-09-30 | $68.72M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $44.31M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $50.89M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $50.75M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $47.06M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $43.96M 10-Q · filed 2020-08-04 |
| 2017-12-31 | $78.87M 10-K · filed 2019-03-01 |